# A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

> **NCT04742725** · PHASE2 · COMPLETED · sponsor: **Prothione, LLC** · enrollment: 231 (actual)

## Conditions studied

- Coronavirus Disease 2019 (COVID-19)

## Interventions

- **DRUG:** Placebo
- **DRUG:** Prothione™ (6g)

## Key facts

- **NCT ID:** NCT04742725
- **Lead sponsor:** Prothione, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-25
- **Primary completion:** 2021-09-21
- **Final completion:** 2021-09-21
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2022-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742725, "A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)". Retrieved via MORVS 2026-10-13 from https://api.morvs.ai/clinical/NCT04742725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*